Gelesis
Gelesis is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of obesity and chronic diseases.
Business Model:
Revenue: $167k
Employees: 51-200
Rankings
Industries / Tags:
Detailed Gelesis Information
Geographic Data
Address: 501 Boylston Street
City: Boston
State: MA
Zip: 02116
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$100M
Raised Total:$263M
Social
Metrics
2,085,354Website Global Rank
9,634Website Monthly Traffic
Twitter Followers
Description
Gelesis is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of obesity and chronic diseases.
Contact Phone:
+16174564718
Contact Email:
Gelesis went public on 1/14/2022 on the NYSE
Listed Exchange:
NYSE
IPO Date:
1/14/2022
IPO Valuation:
$1B
Ticker Symbol:
GLS
Amount Raised:
$105M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
